{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:57:34Z","timestamp":1794272254010,"version":"4.9.0"},"reference-count":68,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science, Research and Innovation Fund (NSRF) and Prince of Songkla University","award":["MED6601085S and MED6505043S"],"award-info":[{"award-number":["MED6601085S and MED6505043S"]}]},{"name":"Royal Golden Jubilee PhD scholarship","award":["NRCT5-RGJ63019-161"],"award-info":[{"award-number":["NRCT5-RGJ63019-161"]}]},{"name":"Faculty of Medicine, Prince of Songkla University, Thailand","award":["02\/2019"],"award-info":[{"award-number":["02\/2019"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Patient-derived advanced prostate cancer organoids have been developed to mimic tumor heterogeneity and beneficially predict optimized drugs for specific patients. The organoids are promising functional drug screening models which can capture patient outcomes. However, organoid development from transurethral resection of the prostate (TUR-P) has been hampered by a low success rate, and the cost of culture should be reduced for realistically clinical settings. In our study, we aimed to improve the success rate and reduce the cost of establishing advanced prostate cancer organoids from TUR-P specimens. Methods: We optimized and improved both the organoid culture protocol and the fetal bovine serum (FBS) based-organoid culture medium, which is suitable for performing drug testing in a short turnaround time. To confirm that the generated organoids could recapitulate the tumor heterogeneity of original tissues, the organoids were validated with histological, immunohistochemical, and genomic analyses. Results: Following the optimized protocol, we successfully generated organoids in approximately 18 out of 29 cases (or 62.07%), which exhibited effective growth and survival. In addition, we found that the established organoids efficiently identified and captured tumor characteristics present in their matched original tissues, as indicated by histological, immunohistochemical, and comprehensive genomic analysis. As a proof of concept for personalized medicine, the generated organoids were treated with anti-cancer drugs, including docetaxel and enzalutamide in parallel with the clinical treatments. Interestingly, the in vitro drug screening results were positively correlated with the patient outcomes at the clinical level. Conclusions: Taken together, the established APC organoids were able to precisely predict patients\u2019 outcomes for treatment decision-making within a month in a cost-effective manner.<\/jats:p>","DOI":"10.3390\/cancers17243973","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T14:04:40Z","timestamp":1765548280000},"page":"3973","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Patient-Derived Organoid Platform from TUR-P Samples Enables Precision Drug Screening in Advanced Prostate Cancer"],"prefix":"10.3390","volume":"17","author":[{"given":"Zaukir Bostan","family":"Ali","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mooktapa","family":"Plikomol","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanan","family":"Bejrananda","sequence":"additional","affiliation":[{"name":"Urology Unit, Department of Surgery, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paramee","family":"Thongsuksai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1178-3895","authenticated-orcid":false,"given":"Pokphon","family":"Khirilak","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natthapon","family":"Khongcharoen","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"},{"name":"Translational Medicine Research Center, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Ulhaka","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratsamaporn","family":"Nontikarn","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onpawee","family":"Phanthuvet","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3068-2412","authenticated-orcid":false,"given":"Pasarat","family":"Khongkow","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"},{"name":"Translational Medicine Research Center, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"ref_1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","unstructured":"Schaeffer, E.M. (2023). NCCN Clinical Practice Guidelines in Oncology (Prostate Cancer), National Comprehensive Cancer Network."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Hoeh, B., W\u00fcrnschimmel, C., Flammia, R.S., Horlemann, B., Sorce, G., Chierigo, F., Tian, Z., Saad, F., Graefen, M., and Gallucci, M. (2021). Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.778858"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s43018-020-00141-0","article-title":"Accelerating precision medicine in metastatic prostate cancer","volume":"1","author":"Mateo","year":"2020","journal-title":"Nat. Cancer"},{"key":"ref_5","unstructured":"TCGA (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163, 1011\u20131025."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Nevedomskaya, E., Baumgart, S.J., and Haendler, B. (2018). Recent Advances in Prostate Cancer Treatment and Drug Discovery. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051359"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Namekawa, T., Ikeda, K., Horie-Inoue, K., and Inoue, S. (2019). Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells. Cells, 8.","DOI":"10.3390\/cells8010074"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Fontana, F., Raimondi, M., Marzagalli, M., Sommariva, M., Gagliano, N., and Limonta, P. (2020). Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186806"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/s41467-021-21300-6","article-title":"Patient-derived xenografts and organoids model therapy response in prostate cancer","volume":"12","author":"Karkampouna","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1038\/s41467-021-25175-5","article-title":"The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology","volume":"12","author":"Risbridger","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/path.5698","article-title":"Prostate cancer patient-derived organoids: Detailed outcome from a prospective cohort of 81 clinical specimens","volume":"254","author":"Servant","year":"2021","journal-title":"J. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/s41467-018-04495-z","article-title":"Patient derived organoids to model rare prostate cancer phenotypes","volume":"9","author":"Puca","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3892\/ol.2021.13124","article-title":"Establishment and characterization of prostate organoids from treatment-na\u00efve patients with prostate cancer","volume":"23","author":"Cheaito","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nprot.2016.006","article-title":"Organoid culture systems for prostate epithelial and cancer tissue","volume":"11","author":"Drost","year":"2016","journal-title":"Nat. Protoc."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lee, S., Mendoza, T.R., Burner, D.N., Muldong, M.T., Wu, C.C.N., Arreola-Villanueva, C., Zuniga, A., Greenburg, O., Zhu, W.Y., and Murtadha, J. (2022). Novel Dormancy Mechanism of Castration Resistance in Bone Metastatic Prostate Cancer Organoids. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063203"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13578-022-00866-8","article-title":"Urological cancer organoids, patients\u2019 avatars for precision medicine: Past, present and future","volume":"12","author":"Chen","year":"2022","journal-title":"Cell Biosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2014.08.017","article-title":"Identification of Multipotent Luminal Progenitor Cells in Human Prostate Organoid Cultures","volume":"159","author":"Karthaus","year":"2014","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101408","DOI":"10.1016\/j.isci.2020.101408","article-title":"Fine-Needle Aspiration-Based Patient-Derived Cancer Organoids","volume":"23","author":"Vilgelm","year":"2020","journal-title":"iScience"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Cham, T.-C., Ibtisham, F., Fayaz, M.A., and Honaramooz, A. (2021). Generation of a Highly Biomimetic Organoid, Including Vasculature, Resembling the Native Immature Testis Tissue. Cells, 10.","DOI":"10.3390\/cells10071696"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"109429","DOI":"10.1016\/j.celrep.2021.109429","article-title":"A pan-cancer organoid platform for precision medicine","volume":"36","author":"Larsen","year":"2021","journal-title":"Cell Rep."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Davoudi, Z., Peroutka-Bigus, N., Bellaire, B., Jergens, A., Wannemuehler, M., and Wang, Q. (2021). Gut Organoid as a New Platform to Study Alginate and Chitosan Mediated PLGA Nanoparticles for Drug Delivery. Mar. Drugs, 19.","DOI":"10.3390\/md19050282"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmgh.2018.06.008","article-title":"IL22 Inhibits Epithelial Stem Cell Expansion in an Ileal Organoid Model","volume":"7","author":"Zwarycz","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_25","unstructured":"Hoffman, J.I.E. (2019). Biostatistics for Medical and Biomedical Practitioners, Academic Press."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1038\/s41467-021-22676-1","article-title":"Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week","volume":"12","author":"Hu","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00438-020-01701-w","article-title":"Genetic analysis of tri-allelic patterns at the CODIS STR loci","volume":"295","author":"Yang","year":"2020","journal-title":"Mol. Genet. Genom."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"104705","DOI":"10.1016\/j.yexmp.2021.104705","article-title":"Setting a diagnostic benchmark for tumor BRCA testing: Detection of BRCA1 and BRCA2 large genomic rearrangements in FFPE tissue\u2014A pilot study","volume":"123","author":"Valtcheva","year":"2021","journal-title":"Exp. Mol. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10549-019-05425-3","article-title":"Multiplex ddPCR assay for screening copy number variations in BRCA1 gene","volume":"178","author":"Oscorbin","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Rungkamoltip, P., Khongcharoen, N., Nokchan, N., Bostan Ali, Z., Plikomol, M., Bejrananda, T., Boonchai, S., Chamnina, S., Srakhao, W., and Khongkow, P. (2025). Droplet Digital PCR Improves Detection of BRCA1\/2 Copy Number Variants in Advanced Prostate Cancer. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26146904"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1038\/s41598-022-08520-6","article-title":"Dynamic changes in gene alterations during chemotherapy in metastatic castrate resistant prostate cancer","volume":"12","author":"Tan","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"108931","DOI":"10.1016\/j.isci.2024.108931","article-title":"Circulating tumor DNA and tissue complementarily detect genomic alterations in metastatic hormone-sensitive prostate cancer","volume":"27","author":"Yang","year":"2024","journal-title":"iScience"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4103\/aja202259","article-title":"FOXA1 in prostate cancer","volume":"25","author":"Dong","year":"2023","journal-title":"Asian J. Androl."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Pandey, R., Johnson, N., Cooke, L., Johnson, B., Chen, Y., Pandey, M., Chandler, J., and Mahadevan, D. (2021). TP53 Mutations as a Driver of Metastasis Signaling in Advanced Cancer Patients. Cancers, 13.","DOI":"10.3390\/cancers13040597"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41391-024-00805-3","article-title":"Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration","volume":"28","author":"Zengin","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41416-022-01915-2","article-title":"Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer","volume":"127","author":"Kimura","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_37","unstructured":"Farha, N.G., and Kasi, A. (2024, September 30). Docetaxel, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537242\/."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJMoa1903835","article-title":"Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer","volume":"381","author":"Davis","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1476-4598-10-126","article-title":"Characterisation and manipulation of docetaxel resistant prostate cancer cell lines","volume":"10","author":"Prencipe","year":"2011","journal-title":"Mol. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1038\/s41598-018-21201-7","article-title":"Development of a primary human Small Intestine-on-a-Chip using biopsy-derived organoids","volume":"8","author":"Kasendra","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41551-020-0565-2","article-title":"High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays","volume":"4","author":"Brandenberg","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Bahmad, H.F., Jalloul, M., Azar, J., Moubarak, M.M., Samad, T.A., Mukherji, D., Al-Sayegh, M., and Abou-Kheir, W. (2021). Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.652747"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-022-00272-w","article-title":"Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance","volume":"6","author":"Ge","year":"2022","journal-title":"npj Precis. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.isci.2019.01.028","article-title":"Prostate Stroma Increases the Viability and Maintains the Branching Phenotype of Human Prostate Organoids","volume":"12","author":"Richards","year":"2019","journal-title":"iScience"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1039\/C9LC00496C","article-title":"A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity","volume":"19","author":"Jung","year":"2019","journal-title":"Lab Chip"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41591-021-01398-3","article-title":"An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer","volume":"27","author":"Voabil","year":"2021","journal-title":"Nat. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"775","DOI":"10.5851\/kosfa.2022.e46","article-title":"Review of the Current Research on Fetal Bovine Serum and the Development of Cultured Meat","volume":"42","author":"Lee","year":"2022","journal-title":"Food Sci. Anim. Resour."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4103\/1008-682X.129132","article-title":"Physiological normal levels of androgen inhibit proliferation of prostate cancer cells in vitro","volume":"16","author":"Song","year":"2014","journal-title":"Asian J. Androl."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1021\/acs.jproteome.8b00135","article-title":"Proteomic Analysis of Charcoal-Stripped Fetal Bovine Serum Reveals Changes in the Insulin-like Growth Factor Signaling Pathway","volume":"17","author":"Tu","year":"2018","journal-title":"J. Proteome Res."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Lebedev, T., Mikheeva, A., Gasca, V., Spirin, P., and Prassolov, V. (2025). Systematic Comparison of FBS and Medium Variation Effect on Key Cellular Processes Using Morphological Profiling. Cells, 14.","DOI":"10.3390\/cells14050336"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1038\/s41598-023-29060-7","article-title":"Fetal bovine serum, an important factor affecting the reproducibility of cell experiments","volume":"13","author":"Liu","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1158\/1541-7786.MCR-19-0595","article-title":"IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer","volume":"18","author":"Maynard","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1073\/pnas.1603645113","article-title":"Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay","volume":"113","author":"Park","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Su, R., Chen, L., Jiang, Z., Yu, M., Zhang, W., Ma, Z., Ji, Y., Shen, K., Xin, Z., and Qi, J. (2022). Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.955166"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00428-021-03204-4","article-title":"Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications","volume":"480","author":"Weidemann","year":"2022","journal-title":"Virchows Arch."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11255-014-0834-7","article-title":"Androgen receptor immunohistochemistry in genitourinary neoplasms","volume":"47","author":"Williams","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/jnci\/djab147","article-title":"Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores","volume":"114","author":"Barnes","year":"2022","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/carcin\/bgaa061","article-title":"Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer","volume":"41","author":"Stopsack","year":"2020","journal-title":"Carcinogenesis"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s43856-021-00019-x","article-title":"Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis","volume":"1","author":"Berg","year":"2021","journal-title":"Commun. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41586-019-1347-4","article-title":"Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer","volume":"571","author":"Parolia","year":"2019","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: Origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2021.10.036","article-title":"Inherited TP53 Variants and Risk of Prostate Cancer","volume":"81","author":"Maxwell","year":"2022","journal-title":"Eur. Urol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"11769351221087046","DOI":"10.1177\/11769351221087046","article-title":"Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer","volume":"21","author":"Zhang","year":"2022","journal-title":"Cancer Inform."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.clgc.2023.06.013","article-title":"Case Series of Men with the Germline APC I1307K variant and Treatment-Emergent Neuroendocrine Prostate Cancer","volume":"22","author":"Economides","year":"2024","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/gim.2018.51","article-title":"Measuring coverage and accuracy of whole-exome sequencing in clinical context","volume":"20","author":"Kong","year":"2018","journal-title":"Genet. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5534\/wjmh.210072","article-title":"Genomic Profiling of Prostate Cancer: An Updated Review","volume":"40","author":"Hatano","year":"2022","journal-title":"World J. Mens Health"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","article-title":"Genomic and phenotypic heterogeneity in prostate cancer","volume":"18","author":"Haffner","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"13668","DOI":"10.1038\/ncomms13668","article-title":"Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer","volume":"7","author":"Henzler","year":"2016","journal-title":"Nat. Commun."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/24\/3973\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T05:16:00Z","timestamp":1765948560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/24\/3973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":68,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["cancers17243973"],"URL":"https:\/\/doi.org\/10.3390\/cancers17243973","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]}}}